Statement by CDC Director Thomas R. Frieden, M.D., M.P.H., on Early End of HPTN 052 Study
May 12, 2011
CDC welcomes the report today from NIH that early HIV treatment can dramatically reduce the risk that an HIV-positive person will transmit the virus to their heterosexual partner. The study, known as HPTN 052, showed that early initiation of anti-retroviral therapy (ART) for HIV-positive people who were heterosexual led to a dramatic reduction in HIV transmission to the HIV-uninfected partner.
Original Source: https://tools.cdc.gov/api/embed/downloader/download.asp?m=132608&c=307888